| Malignant Colorectal Neoplasm altered in cohorts of …ALTERED_INderived200 of 529show all (up to 200) |
|---|
| ← altered in cohorts of | CD40 151 / 171 cases (88 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | HNF4A 150 / 171 cases (88 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PCK1 150 / 171 cases (88 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RIMS4 150 / 171 cases (88 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SGK2 150 / 171 cases (88 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TRPC4AP 150 / 171 cases (88 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | BLCAP 149 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | BMP7 149 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | BPI 149 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | BPIFB3 149 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | COX4I2 149 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | EDN3 149 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | EMILIN3 149 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FAM83D 149 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FOXS1 149 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | GCNT7 149 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | HM13 149 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MROH8 149 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MYL9 149 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PIGT 149 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RBM39 149 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RPN2 149 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SLC35C2 149 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SLC9A8 149 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SPO11 149 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SUN5 149 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ADIG 148 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | C20orf173 148 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CNBD2 148 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | EPPIN-WFDC6 148 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ERGIC3 148 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FAM209B 148 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FAM210B 148 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MAFB 148 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MMP24 148 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | OSBPL2 148 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | OSER1 148 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RAE1 148 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RTF2 148 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SERINC3 148 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SNAI1 148 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TP53RK 148 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | VAPB 148 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | WFDC11 148 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | WFDC13 148 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | WFDC3 148 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | APC 5,400 / 7,237 cases (75 %) · ssm · crc_msk_2026 · largest of 24 cohorts | — | — | Rectal Adenocarcinoma | 24 | Observed | cbioportal | graph → |
| ← altered in cohorts of | KCNB1 343 / 461 cases (74 %) · ssm · TCGA-COAD · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | SLC12A5 338 / 461 cases (73 %) · ssm · TCGA-COAD · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | TSHZ2 338 / 461 cases (73 %) · ssm · TCGA-COAD · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | ZMYND8 338 / 461 cases (73 %) · ssm · TCGA-COAD · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | TP53 5,295 / 7,237 cases (73 %) · ssm · crc_msk_2026 · largest of 23 cohorts | — | — | Rectal Adenocarcinoma | 23 | Observed | cbioportal | graph → |
| ← altered in cohorts of | RALGAPB 337 / 461 cases (73 %) · ssm · TCGA-COAD · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | ARFGEF2 336 / 461 cases (73 %) · ssm · TCGA-COAD · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | NCOA6 336 / 461 cases (73 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZNFX1 335 / 461 cases (73 %) · ssm · TCGA-COAD · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | CEP250 334 / 461 cases (72 %) · ssm · TCGA-COAD · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | DDX27 334 / 461 cases (72 %) · ssm · TCGA-COAD · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | KCNQ2 334 / 461 cases (72 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SYCP2 334 / 461 cases (72 %) · ssm · TCGA-COAD · largest of 3 cohorts | — | — | Colon Adenocarcinoma | 3 | Observed | gdc | graph → |
| ← altered in cohorts of | ZNF335 334 / 461 cases (72 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | KIAA1755 333 / 461 cases (72 %) · ssm · TCGA-COAD · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | GNAS 332 / 461 cases (72 %) · ssm · TCGA-COAD · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | PREX1 332 / 461 cases (72 %) · ssm · TCGA-COAD · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | SALL4 332 / 461 cases (72 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ATP9A 331 / 461 cases (72 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PLCG1 331 / 461 cases (72 %) · ssm · TCGA-COAD · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | TGM2 331 / 461 cases (72 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | L3MBTL1 330 / 461 cases (72 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NCOA5 330 / 461 cases (72 %) · ssm · TCGA-COAD · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | CDH26 329 / 461 cases (71 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | KCNG1 329 / 461 cases (71 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MMP9 329 / 461 cases (71 %) · ssm · TCGA-COAD · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | NFATC2 329 / 461 cases (71 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RBPJL 329 / 461 cases (71 %) · ssm · TCGA-COAD · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | SLC13A3 329 / 461 cases (71 %) · ssm · TCGA-COAD · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | ZNF334 329 / 461 cases (71 %) · ssm · TCGA-COAD · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | NCOA3 328 / 461 cases (71 %) · ssm · TCGA-COAD · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | NOL4L 328 / 461 cases (71 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PCIF1 328 / 461 cases (71 %) · ssm · TCGA-COAD · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | SEMG2 328 / 461 cases (71 %) · ssm · TCGA-COAD · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | SOGA1 328 / 461 cases (71 %) · ssm · TCGA-COAD · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | SULF2 328 / 461 cases (71 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZNF217 328 / 461 cases (71 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZSWIM3 328 / 461 cases (71 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ACSS2 327 / 461 cases (71 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CDH22 327 / 461 cases (71 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | COL20A1 327 / 461 cases (71 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | EPB41L1 327 / 461 cases (71 %) · ssm · TCGA-COAD · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | RBL1 327 / 461 cases (71 %) · ssm · TCGA-COAD · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | STK4 327 / 461 cases (71 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TTI1 327 / 461 cases (71 %) · ssm · TCGA-COAD · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | ZBTB46 327 / 461 cases (71 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | APCDD1L 326 / 461 cases (71 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CSE1L 326 / 461 cases (71 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CTCFL 326 / 461 cases (71 %) · ssm · TCGA-COAD · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | ELMO2 326 / 461 cases (71 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FAM83C 326 / 461 cases (71 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LPIN3 326 / 461 cases (71 %) · ssm · TCGA-COAD · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | MATN4 326 / 461 cases (71 %) · ssm · TCGA-COAD · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | PHACTR3 326 / 461 cases (71 %) · ssm · TCGA-COAD · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | SNX21 326 / 461 cases (71 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZHX3 326 / 461 cases (71 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ADNP 325 / 461 cases (70 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | BPIFB6 325 / 461 cases (70 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CHRNA4 325 / 461 cases (70 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CTSA 325 / 461 cases (70 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DLGAP4 325 / 461 cases (70 %) · ssm · TCGA-COAD · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | FAM217B 325 / 461 cases (70 %) · ssm · TCGA-COAD · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | GDF5 325 / 461 cases (70 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | KCNS1 325 / 461 cases (70 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MYBL2 325 / 461 cases (70 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NPEPL1 325 / 461 cases (70 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PTPN1 325 / 461 cases (70 %) · ssm · TCGA-COAD · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | RTEL1 325 / 461 cases (70 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SEMG1 325 / 461 cases (70 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | STAU1 325 / 461 cases (70 %) · ssm · TCGA-COAD · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | TOP1 325 / 461 cases (70 %) · ssm · TCGA-COAD · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | ZSWIM1 325 / 461 cases (70 %) · ssm · TCGA-COAD · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | C20orf85 324 / 461 cases (70 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CASS4 324 / 461 cases (70 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CYP24A1 324 / 461 cases (70 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DNMT3B 324 / 461 cases (70 %) · ssm · TCGA-COAD · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | EDEM2 324 / 461 cases (70 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | EYA2 324 / 461 cases (70 %) · ssm · TCGA-COAD · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | JPH2 324 / 461 cases (70 %) · ssm · TCGA-COAD · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | MYT1 324 / 461 cases (70 %) · ssm · TCGA-COAD · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | PABPC1L 324 / 461 cases (70 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PPP1R16B 324 / 461 cases (70 %) · ssm · TCGA-COAD · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | SAMHD1 324 / 461 cases (70 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SRSF6 324 / 461 cases (70 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TAF4 324 / 461 cases (70 %) · ssm · TCGA-COAD · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | TOX2 324 / 461 cases (70 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZBP1 324 / 461 cases (70 %) · ssm · TCGA-COAD · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | ZFP64 324 / 461 cases (70 %) · ssm · TCGA-COAD | — | — | Colon Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZNF512B 324 / 461 cases (70 %) · ssm · TCGA-COAD · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | GDAP1L1 323 / 461 cases (70 %) · ssm · TCGA-COAD · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | PLTP 323 / 461 cases (70 %) · ssm · TCGA-COAD · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | KRAS 3,096 / 7,237 cases (43 %) · ssm · crc_msk_2026 · largest of 20 cohorts | — | — | Rectal Adenocarcinoma | 20 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TTN 278 / 1,015 cases (27 %) · ssm · crc_sysucc_2022 · largest of 13 cohorts | — | — | Colorectal Adenocarcinoma | 13 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PIK3CA 1,486 / 7,237 cases (21 %) · ssm · crc_msk_2026 · largest of 16 cohorts | — | — | Rectal Adenocarcinoma | 16 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PRRC2A 26 / 146 cases (18 %) · ssm · coadread_cass_2020 | — | — | Colorectal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MUC16 167 / 1,015 cases (16 %) · ssm · crc_sysucc_2022 · largest of 11 cohorts | — | — | Colorectal Adenocarcinoma | 11 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PPFIA4 23 / 146 cases (16 %) · ssm · coadread_cass_2020 | — | — | Colorectal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FBXW7 1,127 / 7,237 cases (16 %) · ssm · crc_msk_2026 · largest of 13 cohorts | — | — | Rectal Adenocarcinoma | 13 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TCF7L2 1,088 / 7,035 cases (15 %) · ssm · crc_msk_2026 · largest of 9 cohorts | — | — | Rectal Adenocarcinoma | 9 | Observed | cbioportal | graph → |
| ← altered in cohorts of | NBEAL1 43 / 281 cases (15 %) · ssm · coad_silu_2022 | — | — | Colon Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CPD 22 / 146 cases (15 %) · ssm · coadread_cass_2020 | — | — | Colorectal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SMAD4 1,078 / 7,237 cases (15 %) · ssm · crc_msk_2026 · largest of 12 cohorts | — | — | Rectal Adenocarcinoma | 12 | Observed | cbioportal | graph → |
| ← altered in cohorts of | APC2 41 / 281 cases (15 %) · ssm · coad_silu_2022 | — | — | Colon Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | LMAN1 41 / 281 cases (15 %) · ssm · coad_silu_2022 | — | — | Colon Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | HRNR 90 / 619 cases (15 %) · ssm · coadread_dfci_2016 · largest of 2 cohorts | — | — | Colorectal Adenocarcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SYNE1 147 / 1,015 cases (14 %) · ssm · crc_sysucc_2022 · largest of 10 cohorts | — | — | Colorectal Adenocarcinoma | 10 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MTUS2 21 / 146 cases (14 %) · ssm · coadread_cass_2020 | — | — | Colorectal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DIDO1 89 / 619 cases (14 %) · ssm · coadread_dfci_2016 · largest of 2 cohorts | — | — | Colorectal Adenocarcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SEC31A 40 / 281 cases (14 %) · ssm · coad_silu_2022 | — | — | Colon Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SHANK1 40 / 281 cases (14 %) · ssm · coad_silu_2022 | — | — | Colon Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | STAB1 39 / 281 cases (14 %) · ssm · coad_silu_2022 | — | — | Colon Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SYCP1 39 / 281 cases (14 %) · ssm · coad_silu_2022 | — | — | Colon Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | NUPR2 20 / 146 cases (14 %) · ssm · coadread_cass_2020 | — | — | Colorectal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | HMCN2 38 / 281 cases (14 %) · ssm · coad_silu_2022 | — | — | Colon Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | BOD1L1 37 / 281 cases (13 %) · ssm · coad_silu_2022 | — | — | Colon Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | LRTM3 37 / 281 cases (13 %) · ssm · coad_silu_2022 · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | RBM27 36 / 281 cases (13 %) · ssm · coad_silu_2022 | — | — | Colon Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TBC1D23 36 / 281 cases (13 %) · ssm · coad_silu_2022 | — | — | Colon Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TDRD6 36 / 281 cases (13 %) · ssm · coad_silu_2022 | — | — | Colon Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ARID1A 912 / 7,237 cases (13 %) · ssm · crc_msk_2026 · largest of 12 cohorts | — | — | Rectal Adenocarcinoma | 12 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CCDC73 35 / 281 cases (12 %) · ssm · coad_silu_2022 | — | — | Colon Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DNAH12 35 / 281 cases (12 %) · ssm · coad_silu_2022 | — | — | Colon Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | LARP7 35 / 281 cases (12 %) · ssm · coad_silu_2022 | — | — | Colon Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | NDUFC2 35 / 281 cases (12 %) · ssm · coad_silu_2022 | — | — | Colon Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | LRP1 77 / 619 cases (12 %) · ssm · coadread_dfci_2016 · largest of 4 cohorts | — | — | Colorectal Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | OBSCN 126 / 1,015 cases (12 %) · ssm · crc_sysucc_2022 · largest of 8 cohorts | — | — | Colorectal Adenocarcinoma | 8 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FLG2 75 / 619 cases (12 %) · ssm · coadread_dfci_2016 | — | — | Colorectal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ABCC5 34 / 281 cases (12 %) · ssm · coad_silu_2022 | — | — | Colon Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | COBLL1 34 / 281 cases (12 %) · ssm · coad_silu_2022 | — | — | Colon Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CPLANE1 34 / 281 cases (12 %) · ssm · coad_silu_2022 | — | — | Colon Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | HERC1 34 / 281 cases (12 %) · ssm · coad_silu_2022 | — | — | Colon Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SOX9 869 / 7,237 cases (12 %) · ssm · crc_msk_2026 · largest of 10 cohorts | — | — | Rectal Adenocarcinoma | 10 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MKI67 74 / 619 cases (12 %) · ssm · coadread_dfci_2016 | — | — | Colorectal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CLOCK 33 / 281 cases (12 %) · ssm · coad_silu_2022 | — | — | Colon Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DNAH14 33 / 281 cases (12 %) · ssm · coad_silu_2022 | — | — | Colon Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DOCK4 33 / 281 cases (12 %) · ssm · coad_silu_2022 | — | — | Colon Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | KIF1A 33 / 281 cases (12 %) · ssm · coad_silu_2022 | — | — | Colon Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SLC60A2 33 / 281 cases (12 %) · ssm · coad_silu_2022 | — | — | Colon Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SPTBN4 33 / 281 cases (12 %) · ssm · coad_silu_2022 | — | — | Colon Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | VPS13D 33 / 281 cases (12 %) · ssm · coad_silu_2022 | — | — | Colon Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ZMYM4 33 / 281 cases (12 %) · ssm · coad_silu_2022 | — | — | Colon Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FLG 116 / 1,015 cases (11 %) · ssm · crc_sysucc_2022 · largest of 8 cohorts | — | — | Colorectal Adenocarcinoma | 8 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ADAMTSL1 32 / 281 cases (11 %) · ssm · coad_silu_2022 | — | — | Colon Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ADCY8 32 / 281 cases (11 %) · ssm · coad_silu_2022 | — | — | Colon Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ADGRB3 32 / 281 cases (11 %) · ssm · coad_silu_2022 | — | — | Colon Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CEP290 32 / 281 cases (11 %) · ssm · coad_silu_2022 | — | — | Colon Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | HPS1 32 / 281 cases (11 %) · ssm · coad_silu_2022 | — | — | Colon Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | JARID2 32 / 281 cases (11 %) · ssm · coad_silu_2022 | — | — | Colon Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | LMTK3 32 / 281 cases (11 %) · ssm · coad_silu_2022 | — | — | Colon Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PCDHB5 32 / 281 cases (11 %) · ssm · coad_silu_2022 | — | — | Colon Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PKDREJ 32 / 281 cases (11 %) · ssm · coad_silu_2022 | — | — | Colon Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PTPRQ 32 / 281 cases (11 %) · ssm · coad_silu_2022 | — | — | Colon Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SMC6 32 / 281 cases (11 %) · ssm · coad_silu_2022 | — | — | Colon Adenocarcinoma | 1 | Observed | cbioportal | graph → |